Quan, Lin <br/><br/>
Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF.  [electronic resource] 

 -  Molecular medicine reports  Apr 2016 
 - 3319-25 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-3004 
<br/><br/><label>Standard No.: </label>10.3892/mmr.2016.4937  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Western<br/>Conjunctivitis, Allergic--drug therapy<br/>Cytokines--analysis<br/>Disease Models, Animal<br/>Drug Therapy, Combination<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--analysis<br/>Histamine--toxicity<br/>Immunoglobulin E--analysis<br/>Mice<br/>Mice, Inbred BALB C<br/>Naphazoline--therapeutic use<br/>Nerve Growth Factor--analysis<br/>Olopatadine Hydrochloride--therapeutic use<br/>Ovalbumin--immunology<br/>Vascular Endothelial Growth Factor A--metabolism